164 related articles for article (PubMed ID: 36089892)
21. Fanconi anemia-D1 due to homozygosity for the BRCA2 gene Cypriot founder mutation: A case report.
Loizidou MA; Hadjisavvas A; Tanteles GA; Spanou-Aristidou E; Kyriacou K; Christophidou-Anastasiadou V
Oncol Lett; 2016 Jan; 11(1):471-473. PubMed ID: 26834852
[TBL] [Abstract][Full Text] [Related]
22. [Fanconi Anemia, Complementation Group D1 Caused by Biallelic Mutations of BRCA2 Gene--Case Report].
Puchmajerová A; Švojgr K; Novotná D; Macháčková E; Sumerauer D; Smíšek P; Kodet R; Kynčl M; Křepelová A; Foretová L
Klin Onkol; 2016; 29 Suppl 1():S89-92. PubMed ID: 26691948
[TBL] [Abstract][Full Text] [Related]
23. Distinct roles of BRCA2 in replication fork protection in response to hydroxyurea and DNA interstrand cross-links.
Rickman KA; Noonan RJ; Lach FP; Sridhar S; Wang AT; Abhyankar A; Huang A; Kelly M; Auerbach AD; Smogorzewska A
Genes Dev; 2020 Jun; 34(11-12):832-846. PubMed ID: 32354836
[TBL] [Abstract][Full Text] [Related]
24. Global and disease-associated genetic variation in the human Fanconi anemia gene family.
Rogers KJ; Fu W; Akey JM; Monnat RJ
Hum Mol Genet; 2014 Dec; 23(25):6815-25. PubMed ID: 25104853
[TBL] [Abstract][Full Text] [Related]
25. The causes of Fanconi anemia in South Asia and the Middle East: A case series and review of the literature.
Thompson AS; Saba N; McReynolds LJ; Munir S; Ahmed P; Sajjad S; Jones K; Yeager M; Donovan FX; Chandrasekharappa SC; Alter BP; Savage SA; Rehman S
Mol Genet Genomic Med; 2021 Jul; 9(7):e1693. PubMed ID: 33960719
[TBL] [Abstract][Full Text] [Related]
26. Ablation of the Brca1-Palb2 Interaction Phenocopies Fanconi Anemia in Mice.
Park D; Bergin SM; Jones D; Ru P; Koivisto CS; Jeon YJ; Sizemore GM; Kladney RD; Hadjis A; Shakya R; Ludwig T
Cancer Res; 2020 Oct; 80(19):4172-4184. PubMed ID: 32732220
[TBL] [Abstract][Full Text] [Related]
27. Biallelic mutations in BRCA1 cause a new Fanconi anemia subtype.
Sawyer SL; Tian L; Kähkönen M; Schwartzentruber J; Kircher M; ; ; Majewski J; Dyment DA; Innes AM; Boycott KM; Moreau LA; Moilanen JS; Greenberg RA
Cancer Discov; 2015 Feb; 5(2):135-42. PubMed ID: 25472942
[TBL] [Abstract][Full Text] [Related]
28. Hypomorphic Brca2 and Rad51c double mutant mice display Fanconi anemia, cancer and polygenic replication stress.
Tomaszowski KH; Roy S; Guerrero C; Shukla P; Keshvani C; Chen Y; Ott M; Wu X; Zhang J; DiNardo CD; Schindler D; Schlacher K
Nat Commun; 2023 Mar; 14(1):1333. PubMed ID: 36906610
[TBL] [Abstract][Full Text] [Related]
29. Compromised repair of radiation-induced DNA double-strand breaks in Fanconi anemia fibroblasts in G2.
Zahnreich S; Weber B; Rösch G; Schindler D; Schmidberger H
DNA Repair (Amst); 2020 Dec; 96():102992. PubMed ID: 33069004
[TBL] [Abstract][Full Text] [Related]
30. Fanconi anemia with biallelic FANCD1/BRCA2 mutations - Case report of a family with three affected children.
Svojgr K; Sumerauer D; Puchmajerova A; Vicha A; Hrusak O; Michalova K; Malis J; Smisek P; Kyncl M; Novotna D; Machackova E; Jencik J; Pycha K; Vaculik M; Kodet R; Stary J
Eur J Med Genet; 2016 Mar; 59(3):152-7. PubMed ID: 26657402
[TBL] [Abstract][Full Text] [Related]
31. Chromosome Instability in Fanconi Anemia: From Breaks to Phenotypic Consequences.
García-de-Teresa B; Rodríguez A; Frias S
Genes (Basel); 2020 Dec; 11(12):. PubMed ID: 33371494
[TBL] [Abstract][Full Text] [Related]
32. Tetratricopeptide-motif-mediated interaction of FANCG with recombination proteins XRCC3 and BRCA2.
Hussain S; Wilson JB; Blom E; Thompson LH; Sung P; Gordon SM; Kupfer GM; Joenje H; Mathew CG; Jones NJ
DNA Repair (Amst); 2006 May; 5(5):629-40. PubMed ID: 16621732
[TBL] [Abstract][Full Text] [Related]
33. Esophageal cancer as initial presentation of Fanconi anemia in patients with a hypomorphic
Lach FP; Singh S; Rickman KA; Ruiz PD; Noonan RJ; Hymes KB; DeLacure MD; Kennedy JA; Chandrasekharappa SC; Smogorzewska A
Cold Spring Harb Mol Case Stud; 2020 Dec; 6(6):. PubMed ID: 33172906
[TBL] [Abstract][Full Text] [Related]
34. The role of Fanconi anemia/BRCA genes in zebrafish sex determination.
Rodríguez-Marí A; Postlethwait JH
Methods Cell Biol; 2011; 105():461-90. PubMed ID: 21951543
[TBL] [Abstract][Full Text] [Related]
35. Biallelic germline BRCA1 mutations in a patient with early onset breast cancer, mild Fanconi anemia-like phenotype, and no chromosome fragility.
Keupp K; Hampp S; Hübbel A; Maringa M; Kostezka S; Rhiem K; Waha A; Wappenschmidt B; Pujol R; Surrallés J; Schmutzler RK; Wiesmüller L; Hahnen E
Mol Genet Genomic Med; 2019 Sep; 7(9):e863. PubMed ID: 31347298
[TBL] [Abstract][Full Text] [Related]
36. Fanconi anaemia and cancer: an intricate relationship.
Nalepa G; Clapp DW
Nat Rev Cancer; 2018 Mar; 18(3):168-185. PubMed ID: 29376519
[TBL] [Abstract][Full Text] [Related]
37. Genetic counseling for Fanconi anemia: crosslinking disciplines.
Zierhut HA; Tryon R; Sanborn EM
J Genet Couns; 2014 Dec; 23(6):910-21. PubMed ID: 25236480
[TBL] [Abstract][Full Text] [Related]
38. Alpha-fetoprotein and Fanconi Anemia: Relevance to DNA Repair and Breast Cancer Susceptibility.
Lakhi NA; Mizejewski GJ
Fetal Pediatr Pathol; 2017 Feb; 36(1):49-61. PubMed ID: 27690720
[TBL] [Abstract][Full Text] [Related]
39. Fanconi anemia: correlating central nervous system malformations and genetic complementation groups.
Johnson-Tesch BA; Gawande RS; Zhang L; MacMillan ML; Nascene DR
Pediatr Radiol; 2017 Jun; 47(7):868-876. PubMed ID: 28283722
[TBL] [Abstract][Full Text] [Related]
40. Individuals with FANCM biallelic mutations do not develop Fanconi anemia, but show risk for breast cancer, chemotherapy toxicity and may display chromosome fragility.
Catucci I; Osorio A; Arver B; Neidhardt G; Bogliolo M; Zanardi F; Riboni M; Minardi S; Pujol R; Azzollini J; Peissel B; Manoukian S; De Vecchi G; Casola S; Hauke J; Richters L; Rhiem K; Schmutzler RK; Wallander K; Törngren T; Borg Å; Radice P; Surrallés J; Hahnen E; Ehrencrona H; Kvist A; Benitez J; Peterlongo P
Genet Med; 2018 Apr; 20(4):452-457. PubMed ID: 28837162
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
